Results

Total Results: 272 records

Showing results for "end stage renal".

261. Data-Points-7-Tables (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-7-tables.xls
     August 25, 2011 - Ingredient, Age, Gender, and Race Note: A dash signifies a small cell count (less than 11); ESRD = end … stage renal disease.

262. Improving Medication Safety in High Risk Medicare Beneficiaries Toolkit (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research.pdf
     July 01, 2012 - At the end of the initial patient visit and following resolution of any drug related problems, the MTM … Mellitus □ Hypokalemia □ Atrial Fib/Atrial Flutter □ DVT/PE □ Kidney Transplant □ Chronic Renal … _ / ___ ___ / ___ ___ □ Yes □ No ___ ___ / ___ ___ / ___ ___ □ Yes □ No END

263. Disposition of Comments for Quality Improvement Interventions To Address Health Disparities (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/disparities-quality-improvement_disposition-comments.pdf
     August 27, 2012 - The first use of much of this dates back 60 years or more (to the end of the WWII), so you might indicate … No papers discussing end stage renal disease or cystic fibrosis were eligible for inclusion. … depression...I think the findings are that women were receiving better care at baseline, and that by the end … The take home message from this report for me is much more like: “At this stage, and with the available

264. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/infectiousdisease_hi_impact.pdf
     December 01, 2013 - Based on this input, our overall assessment is that this intervention is in the higher end of the high … Based on this input, our overall assessment is that this intervention is in the lower end of the high … users of emtricitabine/tenofovir should be monitored for potential side effects. 48 Decline in renal … Based on this input, our overall assessment is that this intervention is in the higher end of the high … Based on this input, our overall assessment is that this intervention is in the higher end of the high

265. Data-Points-7-Tables1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-7-tables1.pdf
     August 22, 2011 - Ingredient, Age, Gender, and Race Note: An asterisk (*) signifies a small cell count (less than 11); ESRD = end … stage renal disease.

266. Data-Points-7-Tables (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-7-tables.pdf
     August 22, 2011 - Ingredient, Age, Gender, and Race Note: An asterisk (*) signifies a small cell count (less than 11); ESRD = end … stage renal disease.

267. App-D-Surv-Report-3-Noninvasive-Nonpharma 0 (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/app-d-surv-report-3-noninvasive-nonpharma_0.xlsx
     January 01, 2022 - all six treatment sessions and to attend follow-up visits for at least 12 months (52 weeks) after the end … 11.69), p=NR TSK: 23.02 (6.26) vs. 25.13 (6.85), p=NR NR NR One serious adverse event occurred at the end … within each treatment arm (yoga=A1 and A2, PT=B1 and B2) did not differ in primary outcomes at the end … Recieved 12 weekly sessions of RFCBT at the end of the study. A vs. … sciatica; ongoing pregnancy; hypertension, cardiovascular disease, diabetes mellitus, liver disease, renal

268. Infectious Disease Including HIV/AIDS #09 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/09_infectiousdisease_potential_high_impact_june_2012.pdf
     January 01, 2012 - Based on this input, our overall assessment is that this intervention is in the higher end of the high-potential-impact … Based on this input, our overall assessment is that this intervention is in the lower end of the high-potential … Decline in renal function and proteinuria may be related to long-term use of emtricitabine/tenofovir … Based on this input, our overall assessment is that this intervention is in the higher end of the high-potential … Based on this input, our overall assessment is that this intervention is in the higher end of the high

269. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
     October 01, 2015 - Based on this input, our overall assessment is that this intervention is in the high end of the high-impact-potential … rejection, arrhythmias, BOS, narrowing of air passages, primary graft dysfunction or lung not responding, renal

270. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
     September 25, 2013 - (e.g., patients with heart failure, obesity, diabetes, acute coronary syndrome presentation, and renal … aggregation (FPA), which is related to light transmission measured at a specific time point near the end

271. Data-Points-6-Tables (xls file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-6-tables.xls
     January 01, 2006 - Ingredient, 2006-2009 Note: A single period (.) signifies a small cell count (less than 11); ESRD = end … stage renal disease.

272. Data-Points-6-Tables1 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/data-points-6-tables1.pdf
     January 01, 2009 - Disabled/ESRD = under 65; ESRD = end stage renal disease; AI/AN = American Indian or Alaska Native